Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
Vicks accrued a total of 4.3 billion impressions on an estimated national TV ad spend of $18.9 million. The top network for ...
Tremfya’s reign atop the TV pharma ad rankings continued for yet another month as the Johnson & Johnson brand topped iSpot.tv’s list for October. Tremyfa achieved an impressions share of voice (SOV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results